MyMD Pharmaceuticals, Inc.
Climate Impact & Sustainability Data (2021-03, 2022-06-30)
Reporting Period: 2021-03
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- Recent business combination and related transactions (merger, asset contribution to Oravax, Supera Purchase, reverse stock split), requiring significant resources for closing transactions, post-closing transition activities, and preparation of unaudited interim financials. Resignation of principal executive officer and appointment of a new one, necessitating coordination of two management teams.
Mitigation Strategies
- Filing the Form 10-Q as soon as practicable within the five-calendar-day extension period provided by Rule 12b-25.
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Period: 2022-06-30
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- Delays in receiving critical clinical supplies from manufacturer in India impacting development plan.
- Difficulty recruiting patients for clinical trials due to COVID-19.
- COVID-19 pandemic impacting regulatory authorities and third parties engaged in product development and testing.
- High share price volatility and reduced market liquidity due to volatile financial markets.
Mitigation Strategies
- Implemented work-from-home policies and modified operations to comply with social distancing recommendations.
- Monitoring COVID-19 situation closely.